Eli Lilly, Verve Therapeutics to seek US antitrust approval
MLex Summary: Eli Lilly and Verve Therapeutics expect to file paperwork with US antitrust authorities for their $1 billion deal today, June 25, Verve said in a filing with the US...To view the full article, register now.
Already a subscriber? Click here to view full article